-
1
-
-
70350075694
-
Neuroscience: Alzheimer's disease
-
Mucke L, (2009) Neuroscience: Alzheimer's disease. Nature 461: 895-897.
-
(2009)
Nature
, vol.461
, pp. 895-897
-
-
Mucke, L.1
-
2
-
-
84871919598
-
Excitotoxicity: bridge to various triggers in neurodegenerative disorders
-
Mehta A, Prabhakar M, Kumar P, Deshmukh R, Sharma PL, (2013) Excitotoxicity: bridge to various triggers in neurodegenerative disorders. Eur J Pharmacol 698: 6-18.
-
(2013)
Eur J Pharmacol
, vol.698
, pp. 6-18
-
-
Mehta, A.1
Prabhakar, M.2
Kumar, P.3
Deshmukh, R.4
Sharma, P.L.5
-
3
-
-
0032902974
-
Oxidative alterations in Alzheimer's disease
-
Markesbery WR, Carney JM, (1999) Oxidative alterations in Alzheimer's disease. Brain Pathol 9: 133-146.
-
(1999)
Brain Pathol
, vol.9
, pp. 133-146
-
-
Markesbery, W.R.1
Carney, J.M.2
-
4
-
-
0028178837
-
beta-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease
-
Butterfield DA, Hensley K, Harris M, Mattson M, Carney J, (1994) beta-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Biochem Biophys Res Commun 200: 710-715.
-
(1994)
Biochem Biophys Res Commun
, vol.200
, pp. 710-715
-
-
Butterfield, D.A.1
Hensley, K.2
Harris, M.3
Mattson, M.4
Carney, J.5
-
5
-
-
0030928406
-
beta-Amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease
-
Butterfield DA, (1997) beta-Amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease. Chem Res Toxicol 10: 495-506.
-
(1997)
Chem Res Toxicol
, vol.10
, pp. 495-506
-
-
Butterfield, D.A.1
-
6
-
-
67849097738
-
Oxidative stress in vascular dementia and Alzheimer's disease: a common pathology
-
Bennett S, Grant MM, Aldred S, (2009) Oxidative stress in vascular dementia and Alzheimer's disease: a common pathology. J Alzheimers Dis 17: 245-257.
-
(2009)
J Alzheimers Dis
, vol.17
, pp. 245-257
-
-
Bennett, S.1
Grant, M.M.2
Aldred, S.3
-
7
-
-
78449282609
-
Metals, oxidative stress and neurodegenerative disorders
-
Jomova K, Vondrakova D, Lawson M, Valko M, (2010) Metals, oxidative stress and neurodegenerative disorders. Mol Cell Biochem 345: 91-104.
-
(2010)
Mol Cell Biochem
, vol.345
, pp. 91-104
-
-
Jomova, K.1
Vondrakova, D.2
Lawson, M.3
Valko, M.4
-
8
-
-
0028233494
-
Hydrogen peroxide mediates amyloid beta protein toxicity
-
Behl C, Davis JB, Lesley R, Schubert D, (1994) Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77: 817-827.
-
(1994)
Cell
, vol.77
, pp. 817-827
-
-
Behl, C.1
Davis, J.B.2
Lesley, R.3
Schubert, D.4
-
9
-
-
33748466130
-
Apoptosis in Alzheimer disease: a mathematical improbability
-
Zhu X, Raina AK, Perry G, Smith MA, (2006) Apoptosis in Alzheimer disease: a mathematical improbability. Curr Alzheimer Res 3: 393-396.
-
(2006)
Curr Alzheimer Res
, vol.3
, pp. 393-396
-
-
Zhu, X.1
Raina, A.K.2
Perry, G.3
Smith, M.A.4
-
10
-
-
57249084239
-
Neuronal cell death in neurodegenerative diseases: recurring themes around protein handling
-
Gorman AM, (2008) Neuronal cell death in neurodegenerative diseases: recurring themes around protein handling. J Cell Mol Med 12: 2263-2280.
-
(2008)
J Cell Mol Med
, vol.12
, pp. 2263-2280
-
-
Gorman, A.M.1
-
11
-
-
84878111480
-
Reconsider Alzheimer's disease by the 'calpain-cathepsin hypothesis'-A perspective review
-
Yamashima T (2013) Reconsider Alzheimer's disease by the 'calpain-cathepsin hypothesis'-A perspective review. Prog Neurobiol.
-
(2013)
Prog Neurobiol
-
-
Yamashima, T.1
-
12
-
-
33744820304
-
Pharmacological treatment of Alzheimer's Disease
-
Bianchetti A, Ranieri P, Margiotta A, Trabucchi M, (2006) Pharmacological treatment of Alzheimer's Disease. Aging Clin Exp Res 18: 158-162.
-
(2006)
Aging Clin Exp Res
, vol.18
, pp. 158-162
-
-
Bianchetti, A.1
Ranieri, P.2
Margiotta, A.3
Trabucchi, M.4
-
13
-
-
12844271665
-
A preclinical view of cholinesterase inhibitors in neuroprotection: do they provide more than symptomatic benefits in Alzheimer's disease?
-
Francis PT, Nordberg A, Arnold SE, (2005) A preclinical view of cholinesterase inhibitors in neuroprotection: do they provide more than symptomatic benefits in Alzheimer's disease? Trends Pharmacol Sci 26: 104-111.
-
(2005)
Trends Pharmacol Sci
, vol.26
, pp. 104-111
-
-
Francis, P.T.1
Nordberg, A.2
Arnold, S.E.3
-
14
-
-
0034082560
-
Cholinesterase inhibitor therapy stabilizes symptoms of Alzheimer disease
-
Giacobini E, (2000) Cholinesterase inhibitor therapy stabilizes symptoms of Alzheimer disease. Alzheimer Dis Assoc Disord 14Suppl 1: S3-10.
-
(2000)
Alzheimer Dis Assoc Disord
, vol.14
, Issue.SUPPL. 1
, pp. 3-10
-
-
Giacobini, E.1
-
15
-
-
77954369899
-
Beyond the cholinergic hypothesis: do current drugs work in Alzheimer's disease?
-
Martorana A, Esposito Z, Koch G, (2010) Beyond the cholinergic hypothesis: do current drugs work in Alzheimer's disease? CNS Neurosci Ther 16: 235-245.
-
(2010)
CNS Neurosci Ther
, vol.16
, pp. 235-245
-
-
Martorana, A.1
Esposito, Z.2
Koch, G.3
-
16
-
-
75049085215
-
Mechanisms of neuroprotective effects of nicotine and acetylcholinesterase inhibitors: role of alpha4 and alpha7 receptors in neuroprotection
-
Akaike A, Takada-Takatori Y, Kume T, Izumi Y, (2010) Mechanisms of neuroprotective effects of nicotine and acetylcholinesterase inhibitors: role of alpha4 and alpha7 receptors in neuroprotection. J Mol Neurosci 40: 211-216.
-
(2010)
J Mol Neurosci
, vol.40
, pp. 211-216
-
-
Akaike, A.1
Takada-Takatori, Y.2
Kume, T.3
Izumi, Y.4
-
17
-
-
84876375022
-
Alzheimer disease pharmacologic treatment and treatment research
-
Schneider LS, (2013) Alzheimer disease pharmacologic treatment and treatment research. Continuum (Minneap Minn) 19: 339-357.
-
(2013)
Continuum (Minneap Minn)
, vol.19
, pp. 339-357
-
-
Schneider, L.S.1
-
18
-
-
84873743958
-
Galantamine increases hippocampal insulin-like growth factor 2 expression via alpha7 nicotinic acetylcholine receptors in mice
-
Kita Y, Ago Y, Takano E, Fukada A, Takuma K, et al. (2013) Galantamine increases hippocampal insulin-like growth factor 2 expression via alpha7 nicotinic acetylcholine receptors in mice. Psychopharmacology (Berl) 225: 543-551.
-
(2013)
Psychopharmacology (Berl)
, vol.225
, pp. 543-551
-
-
Kita, Y.1
Ago, Y.2
Takano, E.3
Fukada, A.4
Takuma, K.5
-
19
-
-
84862785007
-
Donepezil attenuates hippocampal neuronal damage and cognitive deficits after global cerebral ischemia in gerbils
-
Min D, Mao X, Wu K, Cao Y, Guo F, et al. (2012) Donepezil attenuates hippocampal neuronal damage and cognitive deficits after global cerebral ischemia in gerbils. Neurosci Lett 510: 29-33.
-
(2012)
Neurosci Lett
, vol.510
, pp. 29-33
-
-
Min, D.1
Mao, X.2
Wu, K.3
Cao, Y.4
Guo, F.5
-
20
-
-
20444381285
-
Protective effect of donepezil against Abeta(1-40) neurotoxicity in rat septal neurons
-
Kimura M, Akasofu S, Ogura H, Sawada K, (2005) Protective effect of donepezil against Abeta(1-40) neurotoxicity in rat septal neurons. Brain Res 1047: 72-84.
-
(2005)
Brain Res
, vol.1047
, pp. 72-84
-
-
Kimura, M.1
Akasofu, S.2
Ogura, H.3
Sawada, K.4
-
21
-
-
27744436607
-
Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors
-
Arias E, Gallego-Sandin S, Villarroya M, Garcia AG, Lopez MG, (2005) Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors. J Pharmacol Exp Ther 315: 1346-1353.
-
(2005)
J Pharmacol Exp Ther
, vol.315
, pp. 1346-1353
-
-
Arias, E.1
Gallego-Sandin, S.2
Villarroya, M.3
Garcia, A.G.4
Lopez, M.G.5
-
22
-
-
4143103645
-
Acetylcholinesterase inhibitors: novel activities of old molecules
-
Racchi M, Mazzucchelli M, Porrello E, Lanni C, Govoni S, (2004) Acetylcholinesterase inhibitors: novel activities of old molecules. Pharmacol Res 50: 441-451.
-
(2004)
Pharmacol Res
, vol.50
, pp. 441-451
-
-
Racchi, M.1
Mazzucchelli, M.2
Porrello, E.3
Lanni, C.4
Govoni, S.5
-
23
-
-
0032054003
-
Synthesis and evaluation of tacrine-huperzine A hybrids as acetylcolinesterase inhibitors of potential interest for the treatment of Alzheimer's disease
-
Badia A, Baños JE, Camps P, Contreras J, Görbig DM, et al. (1998) Synthesis and evaluation of tacrine-huperzine A hybrids as acetylcolinesterase inhibitors of potential interest for the treatment of Alzheimer's disease. Bioorg Med Chem 6: 427-440.
-
(1998)
Bioorg Med Chem
, vol.6
, pp. 427-440
-
-
Badia, A.1
Baños, J.E.2
Camps, P.3
Contreras, J.4
Görbig, D.M.5
-
24
-
-
0034736034
-
New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease
-
Camps P, El Achab R, Morral J, Muñoz-Torrero D, Badia A, et al. (2000) New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease. J Med Chem 43: 4657-4666.
-
(2000)
J Med Chem
, vol.43
, pp. 4657-4666
-
-
Camps, P.1
El Achab, R.2
Morral, J.3
Muñoz-Torrero, D.4
Badia, A.5
-
25
-
-
0037036219
-
Interaction of a new potent anticholinesterasic compound (+/-)huprine X with muscarinic receptors in rat brain
-
Roman S, Vivas NM, Badia A, Clos MV, (2002) Interaction of a new potent anticholinesterasic compound (+/-)huprine X with muscarinic receptors in rat brain. Neurosci Lett 325: 103-106.
-
(2002)
Neurosci Lett
, vol.325
, pp. 103-106
-
-
Roman, S.1
Vivas, N.M.2
Badia, A.3
Clos, M.V.4
-
26
-
-
0344256513
-
Potentiation effects of (+/-)huprine X, a new acetylcholinesterase inhibitor, on nicotinic receptors in rat cortical synaptosomes
-
Roman S, Badia A, Camps P, Clos MV, (2004) Potentiation effects of (+/-)huprine X, a new acetylcholinesterase inhibitor, on nicotinic receptors in rat cortical synaptosomes. Neuropharmacology 46: 95-102.
-
(2004)
Neuropharmacology
, vol.46
, pp. 95-102
-
-
Roman, S.1
Badia, A.2
Camps, P.3
Clos, M.V.4
-
27
-
-
33744995785
-
Acetylcholinesterase triggers the aggregation of PrP 106-126
-
Pera M, Roman S, Ratia M, Camps P, Munoz-Torrero D, et al. (2006) Acetylcholinesterase triggers the aggregation of PrP 106-126. Biochem Biophys Res Commun 346: 89-94.
-
(2006)
Biochem Biophys Res Commun
, vol.346
, pp. 89-94
-
-
Pera, M.1
Roman, S.2
Ratia, M.3
Camps, P.4
Munoz-Torrero, D.5
-
28
-
-
59049092791
-
Acetylcholinesterase as an amyloid enhancing factor in PrP82-146 aggregation process
-
Pera M, Martinez-Otero A, Colombo L, Salmona M, Ruiz-Molina D, et al. (2009) Acetylcholinesterase as an amyloid enhancing factor in PrP82-146 aggregation process. Mol Cell Neurosci 40: 217-224.
-
(2009)
Mol Cell Neurosci
, vol.40
, pp. 217-224
-
-
Pera, M.1
Martinez-Otero, A.2
Colombo, L.3
Salmona, M.4
Ruiz-Molina, D.5
-
29
-
-
0034284410
-
Huperzine A and tacrine attenuate beta-amyloid peptide-induced oxidative injury
-
Xiao XQ, Wang R, Tang XC, (2000) Huperzine A and tacrine attenuate beta-amyloid peptide-induced oxidative injury. J Neurosc Res 61: 564-9.
-
(2000)
J Neurosc Res
, vol.61
, pp. 564-569
-
-
Xiao, X.Q.1
Wang, R.2
Tang, X.C.3
-
30
-
-
30144437522
-
Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine
-
Wang R, Yan H, Tang XC, (2006) Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine. Acta Pharmacol Sin 27: 1-26.
-
(2006)
Acta Pharmacol Sin
, vol.27
, pp. 1-26
-
-
Wang, R.1
Yan, H.2
Tang, X.C.3
-
31
-
-
85027927074
-
Effect of huprine X on beta-amyloid, synaptophysin and alpha7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice
-
Hedberg MM, Clos MV, Ratia M, Gonzalez D, Lithner CU, et al. (2010) Effect of huprine X on beta-amyloid, synaptophysin and alpha7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice. Neurodegener Dis 7: 379-388.
-
(2010)
Neurodegener Dis
, vol.7
, pp. 379-388
-
-
Hedberg, M.M.1
Clos, M.V.2
Ratia, M.3
Gonzalez, D.4
Lithner, C.U.5
-
32
-
-
84873087083
-
Huprine X and huperzine A improve cognition and regulate some neurochemical processes related with Alzheimer's disease in triple transgenic mice (3xTg-AD)
-
Ratia M, Gimenez-Llort L, Camps P, Muñoz-Torrero D, Perez B, et al. (2013) Huprine X and huperzine A improve cognition and regulate some neurochemical processes related with Alzheimer's disease in triple transgenic mice (3xTg-AD). Neurodegener Dis 11: 129-140.
-
(2013)
Neurodegener Dis
, vol.11
, pp. 129-140
-
-
Ratia, M.1
Gimenez-Llort, L.2
Camps, P.3
Muñoz-Torrero, D.4
Perez, B.5
-
33
-
-
2642680857
-
Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis
-
Stadelmann C, Bruck W, Bancher C, Jellinger K, Lassmann H, (1998) Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis. J Neuropathol Exp Neurol 57: 456-464.
-
(1998)
J Neuropathol Exp Neurol
, vol.57
, pp. 456-464
-
-
Stadelmann, C.1
Bruck, W.2
Bancher, C.3
Jellinger, K.4
Lassmann, H.5
-
34
-
-
17044404593
-
Effects of (+/-)-huprine Y and (+/-)-huprine Z, two new anticholinesterasic drugs, on muscarinic receptors
-
Alcala MM, Maderuelo A, Vivas NM, Camps P, Muñoz-Torrero D, et al. (2005) Effects of (+/-)-huprine Y and (+/-)-huprine Z, two new anticholinesterasic drugs, on muscarinic receptors. Neurosci Lett 379: 106-109.
-
(2005)
Neurosci Lett
, vol.379
, pp. 106-109
-
-
Alcala, M.M.1
Maderuelo, A.2
Vivas, N.M.3
Camps, P.4
Muñoz-Torrero, D.5
-
35
-
-
0037036219
-
Interaction of a new potent anticholinesterasic compound (+/-)huprine X with muscarinic receptors in rat brain
-
Roman S, Vivas NM, Badia A, Clos MV, (2002) Interaction of a new potent anticholinesterasic compound (+/-)huprine X with muscarinic receptors in rat brain. Neurosci Lett 325: 103-106.
-
(2002)
Neurosci Lett
, vol.325
, pp. 103-106
-
-
Roman, S.1
Vivas, N.M.2
Badia, A.3
Clos, M.V.4
-
36
-
-
34547136698
-
Galantamine postischemia provides neuroprotection and memory recovery against transient global cerebral ischemia in gerbils
-
Lorrio S, Sobrado M, Arias E, Roda JM, Garcia AG, et al. (2007) Galantamine postischemia provides neuroprotection and memory recovery against transient global cerebral ischemia in gerbils. J Pharmacol Exp Ther 322: 591-599.
-
(2007)
J Pharmacol Exp Ther
, vol.322
, pp. 591-599
-
-
Lorrio, S.1
Sobrado, M.2
Arias, E.3
Roda, J.M.4
Garcia, A.G.5
-
37
-
-
2342420034
-
Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease
-
Pratico D, Sung S, (2004) Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease. J Alzheimers Dis 6: 171-175.
-
(2004)
J Alzheimers Dis
, vol.6
, pp. 171-175
-
-
Pratico, D.1
Sung, S.2
-
38
-
-
0016830798
-
Nerve growth factor-induced process formation by cultured rat pheochromocytoma cells
-
Tischler AS, Greene LA, (1975) Nerve growth factor-induced process formation by cultured rat pheochromocytoma cells. Nature 258: 341-342.
-
(1975)
Nature
, vol.258
, pp. 341-342
-
-
Tischler, A.S.1
Greene, L.A.2
-
39
-
-
0019506626
-
Regulation of acetylcholinesterase activity by nerve growth factor. Role of transcription and dissociation from effects on proliferation and neurite outgrowth
-
Greene LA, Rukenstein A, (1981) Regulation of acetylcholinesterase activity by nerve growth factor. Role of transcription and dissociation from effects on proliferation and neurite outgrowth. J Biol Chem 256: 6363-6367.
-
(1981)
J Biol Chem
, vol.256
, pp. 6363-6367
-
-
Greene, L.A.1
Rukenstein, A.2
-
40
-
-
18344414746
-
The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction
-
Huang X, Atwood CS, Hartshorn MA, Multhaup G, Goldstein LE, et al. (1999) The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 38: 7609-7616.
-
(1999)
Biochemistry
, vol.38
, pp. 7609-7616
-
-
Huang, X.1
Atwood, C.S.2
Hartshorn, M.A.3
Multhaup, G.4
Goldstein, L.E.5
-
41
-
-
0344688198
-
Galantamine prevents apoptosis induced by beta-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors
-
Arias E, Ales E, Gabilan NH, Cano-Abad MF, Villarroya M, et al. (2004) Galantamine prevents apoptosis induced by beta-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors. Neuropharmacology 46: 103-114.
-
(2004)
Neuropharmacology
, vol.46
, pp. 103-114
-
-
Arias, E.1
Ales, E.2
Gabilan, N.H.3
Cano-Abad, M.F.4
Villarroya, M.5
-
42
-
-
0035919804
-
Hiperzine A protects rat pheochromocytoma cells against oxygen-glucose deprivation
-
Zhou J, Fu Y, Tang XC, (2001) Hiperzine A protects rat pheochromocytoma cells against oxygen-glucose deprivation. NeuroReport 12: 2073-2077.
-
(2001)
NeuroReport
, vol.12
, pp. 2073-2077
-
-
Zhou, J.1
Fu, Y.2
Tang, X.C.3
-
43
-
-
0035964415
-
Huperzine A attenuates hydrogen peroxide induced apoptosis by regulating expression of apoptosis-related genes in rat PC12 cells
-
Wang R, Xiao XQ, Tang XC, (2001) Huperzine A attenuates hydrogen peroxide induced apoptosis by regulating expression of apoptosis-related genes in rat PC12 cells. Neuroreport 12: 2629-2634.
-
(2001)
Neuroreport
, vol.12
, pp. 2629-2634
-
-
Wang, R.1
Xiao, X.Q.2
Tang, X.C.3
-
44
-
-
0037622682
-
Nicotinic acetylcholine receptor-mediated neuroprotection by donepezil against glutamate neurotoxicity in rat cortical neurons
-
Takada Y, Yonezawa A, Kume T, Katsuki H, Kaneko S, et al. (2003) Nicotinic acetylcholine receptor-mediated neuroprotection by donepezil against glutamate neurotoxicity in rat cortical neurons. J Pharmacol Exp Ther 306: 772-777.
-
(2003)
J Pharmacol Exp Ther
, vol.306
, pp. 772-777
-
-
Takada, Y.1
Yonezawa, A.2
Kume, T.3
Katsuki, H.4
Kaneko, S.5
-
45
-
-
33747044365
-
Acetylcholinesterase inhibitors used in treatment of Alzheimer's disease prevent glutamate neurotoxicity via nicotinic acetylcholine receptors and phosphatidylinositol 3-kinase cascade
-
Takada-Takatori Y, Kume T, Sugimoto M, Katsuki H, Sugimoto H, et al. (2006) Acetylcholinesterase inhibitors used in treatment of Alzheimer's disease prevent glutamate neurotoxicity via nicotinic acetylcholine receptors and phosphatidylinositol 3-kinase cascade. Neuropharmacology 51: 474-486.
-
(2006)
Neuropharmacology
, vol.51
, pp. 474-486
-
-
Takada-Takatori, Y.1
Kume, T.2
Sugimoto, M.3
Katsuki, H.4
Sugimoto, H.5
-
46
-
-
27744516086
-
Nicotinic-receptor potentiator drugs, huprine X and galantamine, increase ACh release by blocking AChE activity but not acting on nicotinic receptors
-
Roman S, Badia A, Camps P, Muñoz-Torrero D, Clos MV, (2005) Nicotinic-receptor potentiator drugs, huprine X and galantamine, increase ACh release by blocking AChE activity but not acting on nicotinic receptors. Brain Res 1061: 73-79.
-
(2005)
Brain Res
, vol.1061
, pp. 73-79
-
-
Roman, S.1
Badia, A.2
Camps, P.3
Muñoz-Torrero, D.4
Clos, M.V.5
-
47
-
-
0036667555
-
Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression
-
Zelko IN, Mariani TJ, Folz RJ, (2002) Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med 33: 337-349.
-
(2002)
Free Radic Biol Med
, vol.33
, pp. 337-349
-
-
Zelko, I.N.1
Mariani, T.J.2
Folz, R.J.3
-
48
-
-
34247178359
-
DNA repair in differentiated cells: some new answers to old questions
-
Nouspikel T, (2007) DNA repair in differentiated cells: some new answers to old questions. Neuros 145: 1213-1221.
-
(2007)
Neuros
, vol.145
, pp. 1213-1221
-
-
Nouspikel, T.1
-
49
-
-
0034885975
-
Nicotinic acetylcholine receptors and neurodegenerative disease
-
Nakamura S, Takahashi T, Yamashita H, Kawakami H, (2001) Nicotinic acetylcholine receptors and neurodegenerative disease. Alcohol 24: 79-81.
-
(2001)
Alcohol
, vol.24
, pp. 79-81
-
-
Nakamura, S.1
Takahashi, T.2
Yamashita, H.3
Kawakami, H.4
-
50
-
-
33748960736
-
Neuroprotective effects of galanthamine and tacrine against glutamate neurotoxicity
-
Takada-Takatori Y, Kume T, Sugimoto M, Katsuki H, Niidome T, et al. (2006) Neuroprotective effects of galanthamine and tacrine against glutamate neurotoxicity. Eur J Pharmacol 549: 19-26.
-
(2006)
Eur J Pharmacol
, vol.549
, pp. 19-26
-
-
Takada-Takatori, Y.1
Kume, T.2
Sugimoto, M.3
Katsuki, H.4
Niidome, T.5
-
51
-
-
78649368474
-
Structural and functional neuroprotection in glaucoma: role of galantamine-mediated activation of muscarinic acetylcholine receptors
-
Almasieh M, Zhou Y, Kelly ME, Casanova C, Di PA, (2010) Structural and functional neuroprotection in glaucoma: role of galantamine-mediated activation of muscarinic acetylcholine receptors. Cell Death Dis 1: e27.
-
(2010)
Cell Death Dis
, vol.1
-
-
Almasieh, M.1
Zhou, Y.2
Kelly, M.E.3
Casanova, C.4
Di, P.A.5
-
52
-
-
33646899542
-
Acetyl-L-carnitine protects striatal neurons against in vitro ischemia: the role of endogenous acetylcholine
-
Picconi B, Barone I, Pisani A, Nicolai R, Benatti P, et al. (2006) Acetyl-L-carnitine protects striatal neurons against in vitro ischemia: the role of endogenous acetylcholine. Neuropharmacology 50: 917-923.
-
(2006)
Neuropharmacology
, vol.50
, pp. 917-923
-
-
Picconi, B.1
Barone, I.2
Pisani, A.3
Nicolai, R.4
Benatti, P.5
-
53
-
-
62649162799
-
Muscarinic receptors prevent oxidative stress-mediated apoptosis induced by domoic acid in mouse cerebellar granule cells
-
Giordano G, Li L, White CC, Farin FM, Wilkerson HW, et al. (2009) Muscarinic receptors prevent oxidative stress-mediated apoptosis induced by domoic acid in mouse cerebellar granule cells. J Neurochem 109: 525-538.
-
(2009)
J Neurochem
, vol.109
, pp. 525-538
-
-
Giordano, G.1
Li, L.2
White, C.C.3
Farin, F.M.4
Wilkerson, H.W.5
-
54
-
-
67449155877
-
Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations
-
Kumar P, Kumar A, (2009) Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations. Eur J Pharmacol 615: 91-101.
-
(2009)
Eur J Pharmacol
, vol.615
, pp. 91-101
-
-
Kumar, P.1
Kumar, A.2
-
55
-
-
0032888723
-
Improving effects of huperzine A on abnormal lipid peroxidation and superoxide dismutase in aged rats
-
Shang YZ, Ye JW, Tang XC, (1999) Improving effects of huperzine A on abnormal lipid peroxidation and superoxide dismutase in aged rats. Zhongguo Yao Li Xue Bao 20: 824-828.
-
(1999)
Zhongguo Yao Li Xue Bao
, vol.20
, pp. 824-828
-
-
Shang, Y.Z.1
Ye, J.W.2
Tang, X.C.3
-
56
-
-
0036903919
-
Huperzine B protects rat pheochromocytoma cells against oxygen-glucose deprivation-induced injury
-
Wang ZF, Zhou J, Tang XC, (2002) Huperzine B protects rat pheochromocytoma cells against oxygen-glucose deprivation-induced injury. Acta Pharmacol Sin 23: 1193-1198.
-
(2002)
Acta Pharmacol Sin
, vol.23
, pp. 1193-1198
-
-
Wang, Z.F.1
Zhou, J.2
Tang, X.C.3
-
57
-
-
7244243873
-
Regulation of Cu/Zn-superoxide dismutase expression via the phosphatidylinositol 3 kinase/Akt pathway and nuclear factor-kappaB
-
Rojo AI, Salinas M, Martin D, Perona R, Cuadrado A, (2004) Regulation of Cu/Zn-superoxide dismutase expression via the phosphatidylinositol 3 kinase/Akt pathway and nuclear factor-kappaB. J Neurosci 24: 7324-7334.
-
(2004)
J Neurosci
, vol.24
, pp. 7324-7334
-
-
Rojo, A.I.1
Salinas, M.2
Martin, D.3
Perona, R.4
Cuadrado, A.5
-
58
-
-
0020315499
-
Regulation of muscarinic ligand binding sites by nerve growth factor in PC12 phaeochromocytoma cells
-
Jumblatt JE, Tischler AS, (1982) Regulation of muscarinic ligand binding sites by nerve growth factor in PC12 phaeochromocytoma cells. Nature 297: 152-154.
-
(1982)
Nature
, vol.297
, pp. 152-154
-
-
Jumblatt, J.E.1
Tischler, A.S.2
-
59
-
-
0020554531
-
Increased sodium ion conductance through nicotinic acetylcholine receptor channels in PC12 cells exposed to nerve growth factors
-
Amy CM, Bennett EL, (1983) Increased sodium ion conductance through nicotinic acetylcholine receptor channels in PC12 cells exposed to nerve growth factors. J Neurosci 3: 1547-1553.
-
(1983)
J Neurosci
, vol.3
, pp. 1547-1553
-
-
Amy, C.M.1
Bennett, E.L.2
-
60
-
-
0021061819
-
Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays
-
Mosmann T, (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63.
-
(1983)
J Immunol Methods
, vol.65
, pp. 55-63
-
-
Mosmann, T.1
-
61
-
-
0017184389
-
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
-
Bradford M, (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 248: 248-254.
-
(1976)
Anal Biochem
, vol.248
, pp. 248-254
-
-
Bradford, M.1
|